Dr. Javid J. Moslehi, MD

Dr. Moslehi practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Moslehi's NPI, 1538123716, was assigned on April 14, 2006. Dr. Moslehi graduated from Uconn School Of Medicine in 2001. Dr. Moslehi's California license number on file is C174811.

Dr. Moslehi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Moslehi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Moslehi to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moslehi practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Moslehi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Moslehi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Moslehi's licenses on file in 4 states: California, Tennessee, Alabama and Massachusetts.

Dmand AI lists chronic hypertension, congestive heart failure, coronary artery disease, heart attack, heart valve disorders, high cholesterol and intermittent racing heartbeat (PSVT) among the conditions Dr. Moslehi treats.

CMS data shows 256 Medicare services from Dr. Moslehi across 4 procedure codes in 2024, for 90 Medicare patients. Medicare paid $16,926 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 90 Medicare patients who saw Dr. Moslehi in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moslehi's median patient age at 71, with 39% women.

In 2024, Dr. Moslehi wrote 165 Medicare Part D claims for 35 patients. 95% of them were for generic drugs. CMS names the drug for 78 of them, across 4 drugs with 11 or more claims each, at $5,564 in total drug cost. In 2023, CMS named 110 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Moslehi for performance year 2024, reported as part of a group. Dr. Moslehi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moslehi as offering telehealth.

Dmand AI links 278 papers to Dr. Moslehi, published from 2002 to 2025. 2020 was the busiest year, with 42. The most frequent topics are Cardiovascular Diseases, Immune Checkpoint Inhibitors and Myocarditis. Dr. Moslehi has published most often in Circulation. Dr. Moslehi's most frequent co-authors are Michelle Elizabeth Melisko, MD, Crystal S. Denlinger, MD and Kevin Scott Baker, MD.

Dmand AI links Dr. Moslehi to 2 clinical trials. Conditions studied include Lymphoma and Lymphatic Diseases. Massachusetts General Hospital sponsors the most, 2.

CMS Open Payments shows 234 general payments to Dr. Moslehi from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Pfizer Inc. paid the most, $134,342. It also lists 2 research payments totaling $21,450 from 2022 to 2023.

Dr. Moslehi graduated from Uconn School Of Medicine in 2001.

Dr. Moslehi is in network with 7 carriers, including Aetna, Cigna and United Healthcare. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.